Phathom Pharmaceuticals

IPO

Leading the way to innovative treatments for gastrointestinal diseases

Public · Florham Park, United States · Founded 2018 · $580.3M raised

Employees
201–500
Founded
2018
Business Model
B2B
Total Funding
$580.3M
Last Round
$130.0M Venture RoundJan 2026
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for acid-related gastrointestinal disorders. The company holds exclusive US, European, and Canadian rights to a potassium-competitive acid blocker (PCAB), a next-generation mechanism that offers an alternative to proton pump inhibitors for conditions such as erosive esophagitis and H. pylori infection.

Summary

Phathom Pharmaceuticals is a Biotech company based in Florham Park, United States, founded in 2018. It has raised $580.3M in total across 4 rounds, most recently a $130.0M Venture Round in Jan 2026. Investors include SVB Capital and New Enterprise Associates.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundPublic OfferingJan 2026
$130.0M

Sign up to see all 5 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Phathom Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/phathom-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/phathom-pharmaceuticals" alt="Phathom Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>